Liver Cancer

Review Article

Burden of liver cancer: From epidemiology to prevention
Qianru Li,Maomao Cao,Lin Lei,Fan Yang,He Li,Xinxin Yan,Siyi He,Shaoli Zhang,Yi Teng,Changfa Xia,Wanqing Chen
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma
Hanyuan Liu,Chunmei Wang,Ruiqiang Wang,Hengsong Cao,Yongfang Cao,Tian Huang,Zhengqing Lu,Hua Xiao,Mengcheng Hu,Hanjin Wang,Jun Zhao
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma
Sana Rashid,Yingchuan Sun,Umair Ali Khan Saddozai,Sikandar Hayyat,Muhammad Usman Munir,Muhammad Usman Akbar,Muhammad Babar Khawar,Zhiguang Ren,Xinying Ji,Malik Ihsan Ullah Khan
Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review
Gaoyuan Yang,Huamei Yan,Yongchang Tang,Feng Yuan,Mingbo Cao,Yupeng Ren,Yuxuan Li,Zhiwei He,Xiaorui Su,Zhicheng Yao,Meihai Deng
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road
Yufeng Gu,Shengjun Xu,Zhengxin Wang,Jiayin Yang,Shusen Zheng,Qiang Wei,Zhikun Liu,Xiao Xu

Original Article

Zinc finger protein 296 promotes hepatocellular carcinoma progression via intervening interaction between macrophages and B cells
Nan Xu,Xiaonan Xiang,Huan Chen,Yiyuan Chen,Shuai Wang,Haijun Guo,Xuyong Wei,Jun Chen,Xiao Xu,Qiang Wei
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis
Hongyu Chen,Qiangguo Ao,Yueling Wang,Yue Qian,Qingli Cheng,Wei Zhang
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial
Yupeng Ren,Yuxuan Li,Mingbo Cao,Yongchang Tang,Feng Yuan,Gaoyuan Yang,Zhiwei He,Zheng Shi,Xiaorui Su,Zhicheng Yao,Meihai Deng
Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence
Jianguo Wang,Xiaonan Xiang,Zhixiong Shi,Hui Zhang,Quanbao Zhang,Zhikun Liu,Guangjie Zhao,Chuanxing Wu,Qiang Wei,Lin Zhong,Zhengxin Wang,Guoyue Lv,Shusen Zheng,Xiao Xu
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma
Huigang Li,Zuyuan Lin,Jianyong Zhuo,Modan Yang,Wei Shen,Zhihang Hu,Yichen Ding,Hao Chen,Chiyu He,Xinyu Yang,Siyi Dong,Xuyong Wei,Beicheng Sun,Shusen Zheng,Ren Lang,Di Lu,Xiao Xu
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial
Maomao Cao,Jufang Shi,Changfa Xia,He Li,Wei Cai,Xianyun Qi,Chunyun Dai,Wanqing Chen